Author:
Broderick Ryan C.,Sandler Bryan J.
Publisher
Springer International Publishing
Reference11 articles.
1. Sullivan S, Edmundowicz SA, Thompson CC. Endoscopic bariatric and metabolic therapies: new and emerging technologies. Gastroenterology. 2017;152(7):1791–801.
2. Abu Dayyeh BK, Kumar N, Edmundowicz SA, Jonnalagadda S, Larsen M, Sullivan S, et al. ASGE Bariatric Endoscopy Task Force systematic review and meta-analysis assessing the ASGE PIVI thresholds for adopting endoscopic bariatric therapies. Gastrointest Endosc. 2015;82(3):425–438.e5.
3. Zimmerman MA, Budish RA, Kashyap S, Lindsey SH. HHS public access. N Engl J Med. 2017;130(12):1005–16.
4. Glaysher MA, Mohanaruban A, Prechtl CG, Goldstone AP, Miras AD, Lord J, et al. A randomised controlled trial of a duodenal-jejunal bypass sleeve device (EndoBarrier) compared with standard medical therapy for the management of obese subjects with type 2 diabetes mellitus. BMJ Open. 2017;7(11):e018598.
5. Gersin KS, Keller JE, Stefanidis D, Simms CS, Abraham DD, Deal SE, et al. Duodenal- jejunal bypass sleeve: a totally endoscopic device for the treatment of morbid obesity. Surg Innov. 2007;14(4):275–8.